Zionexa is rated 3 out of 5 in the category in-vivo biomarkers transforming oncology. Read and write reviews about Zionexa. Zionexa is an international and innovative company developing and commercializing molecular imaging solutions, in-vivo biomarkers for targeted therapies in oncology, to improve patients’ pathway and bring them a better quality of life.
Address
42, Avenue de la Grande Armée
Company size
11-50 employees
Headquarters
Paris, Ile-de-France